H. LEE MOFFITT CANCER CTR & RES INST
Program control of CD8+ T cell response to tumors and tumor memory
Program control of CD8+ T cell response to tumors and tumor memory is a funding opportunity from H. LEE MOFFITT CANCER CTR & RES INST, up to 549460, closing April 30, 2030.
Apr 30, 2030
(1369d left)Overview
Abstract CD8+ tumor infiltrating lymphocytes (TILs) are not only critical for the anti-tumor immune response in solid tumors, but also in the success of adoptive cell therapies and in immune check point blockade (ICB) treatments. CD8+ TILs have been shown to be heterogeneous, and in time to progress to a terminally…